Publication:
Corneal intraepithelial neoplasia treated with topical mitomycin-C

dc.contributor.authorBilgin, Burak
dc.contributor.authorÖzdemir, Nusret
dc.contributor.authorKaradağ, Ayşe Sevgi
dc.contributor.institutionBahçeşehir Üniversitesi
dc.contributor.institutionÇukurova Üniversitesi
dc.contributor.institutionAdıyaman Üniversitesi
dc.date.accessioned2025-09-20T20:01:14Z
dc.date.issued2018
dc.date.submitted25.04.2019
dc.identifier.doi10.17826/cumj.333862
dc.identifier.endpage758
dc.identifier.issn2602-3032
dc.identifier.issn2602-3040
dc.identifier.issue3
dc.identifier.startpage755
dc.identifier.urihttps://hdl.handle.net/20.500.14719/5463
dc.identifier.volume43
dc.relation.journalCukurova Medical Journal
dc.subjectGöz Hastalıkları
dc.titleCorneal intraepithelial neoplasia treated with topical mitomycin-C
dc.typeLetter To Editor
dcterms.references1. Nelson KD, McSoley JJ. Clinical findings and management of conjunctival intraepithelial neoplasia. Optometry. 2011,82:15-21.,2. Prabhasawat P, Tarinvorakup P, Tesavibul N, Uiprasertkul M, Kosrirukvongs P, Booranapong W et al. Topical 0.002% mitomycin C for the treatment of conjunctival-corneal intraepithelial neoplasia and squamous cell carcinoma. Cornea. 2005,24(4): 443-8.,3. Giaconi JA, Karp CL. Current treatment options for conjunctival and corneal intraepithelial neoplasia. Ocul Surf. 2003,1:66-73.,4. Kao AA, Galor A, Karp CL, Abdelaziz A, Feuer WJ, Dubovy SR. Clinicopathologic correlation of ocular surface squamous neoplasms at Bascom Palmer Eye Institute: 2001 to 2010. Ophthalmology. 2012,119:1773-6.,5. Anne Vollmar A, De La Torre D, Schmiedecke S. Use of interferon alpha b2 in treatment of corneal-conjunctival intraepithelial neoplasia. Optometry. 2009,80:299-300.,6. Saroj G. Corneal and conjunctival intraepithelial neoplasia-A case report. People’s Journal Scientific Research. 2010,3:31-2.,7. Frucht-Pery J, Rozenman Y. Mitomycin C therapy for corneal intraepithelial neoplasia. Am J Ophthalmol. 1994,117:164-8.,8. Frucht-Pery J, Rozenman Y, Pe'er J. Topical mitomicin C for partially excised conjunctival squamous cell carcinoma. Ophthalmology. 2002,109:548-52.,9. Shields CL, Nasiripour M, Shields JA. Topical mitomicin C for extensive, recurrent conjunctival-corneal squamous cell carcinoma. Am J Ophthalmol. 2002,133:601-6.,10. Kemp EG, Harnett AN, Chatterjee S. Preoperative topical and intraoperative local mitomicin C adjuvant therapy in the management of ocular surface neoplasias. Br J Ophthalmol. 2002,86:31-4.,11. Chalasani R, Giblin M, Conway RM. Role of topical chemotherapy for primary acquired melanosis and malignant melanoma of the conjunctiva and cornea: review of the evidence and recommendations for treatment. Clin Experiment Ophthalmol. 2006 ,34:708-14.,12. Rubinfeld RS, Pfister RR, Stein RM, Foster CS, Martin NF, Stoleru S et al. Serious complications of topical mitomycin-C after pterygium surgery.\r\nOphthalmology. 1992,99:1647-54.,13. Prabhasawat P, Tarinvorakup P, Tesavibul N, Uiprasertkul M, Kosrirukvongs P, Booranapong W, et al. Topical 0.002% mitomycin C for the treatment of conjunctival-corneal intraepithelial neoplasia and squamous cell carcinoma. Cornea. 2005,24:443-8.,14. Zaki AA, Farid SF. Management of intraepithelial and invasive neoplasia of the cornea and conjunctiva: a long-term follow up. Cornea. 2009,28:986-8.
dspace.entity.typePublication
local.indexed.atTRDizin

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Topikal mitomisin-C ile tedavi edilen korneal intraepitelyal neoplazi.pdf
Size:
295.07 KB
Format:
Adobe Portable Document Format